New research investigates cannabis and psychosis, and buprenorphine with ketamine lowers suicidality in adults with major depressive disorder.
New research on the relationship between cannabis and psychosis was released, and a presentation on how low‐dose buprenorphine combined with ketamine reduced suicidality in adults with major depressive disorder was published and presented at the annual meeting of the American Psychiatric Association (APA).
No takes yet. Share an insight, caveat, or question.
Alison Knopf (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: